JoonyO
GLP-1爱好者
- Member Since
- Oct 26, 2025
- Posts
- 5
- Likes Received
- 0

here from the latest Reta trial results ( first I'd heard of it ) is what many of us refer to as allodynia? The descriptions sure sound similar.
Lilly’s Retatrutide Scores Triple Trial Triumph With 26% Weight Loss, But New Safety Signal Emerges
Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called dysesthesia, has emerged in the late-stage TRIUMPH-4 trial.
www.biospace.com
Lilly’s Retatrutide Scores Triple Trial Triumph With 26% Weight Loss, But New Safety Signal Emerges
Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called dysesthesia, has emerged in the late-stage TRIUMPH-4 trial.
www.biospace.com